Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Elife ; 82019 10 22.
Artigo em Inglês | MEDLINE | ID: mdl-31637998

RESUMO

Monocyte counts are increased during human tuberculosis (TB) but it has not been determined whether Mycobacterium tuberculosis (Mtb) directly regulates myeloid commitment. We demonstrated that exposure to Mtb directs primary human CD34+ cells to differentiate into monocytes/macrophages. In vitro myeloid conversion did not require type I or type II IFN signaling. In contrast, Mtb enhanced IL-6 responses by CD34+ cell cultures and IL-6R neutralization inhibited myeloid differentiation and decreased mycobacterial growth in vitro. Integrated systems biology analysis of transcriptomic, proteomic and genomic data of large data sets of healthy controls and TB patients established the existence of a myeloid IL-6/IL6R/CEBP gene module associated with disease severity. Furthermore, genetic and functional analysis revealed the IL6/IL6R/CEBP gene module has undergone recent evolutionary selection, including Neanderthal introgression and human pathogen adaptation, connected to systemic monocyte counts. These results suggest Mtb co-opts an evolutionary recent IFN-IL6-CEBP feed-forward loop, increasing myeloid differentiation linked to severe TB in humans.


Assuntos
Proteínas Estimuladoras de Ligação a CCAAT/metabolismo , Interferons/metabolismo , Interleucina-6/metabolismo , Monócitos/metabolismo , Mycobacterium tuberculosis/imunologia , Tuberculose/imunologia , Antígenos CD34 , Proteínas Estimuladoras de Ligação a CCAAT/genética , Diferenciação Celular , Proliferação de Células , Citocinas/genética , Citocinas/metabolismo , Estudo de Associação Genômica Ampla , Humanos , Hidrolases , Interferons/genética , Interleucina-6/genética , Macrófagos/microbiologia , Monócitos/microbiologia , Mycobacterium tuberculosis/patogenicidade , Células Mieloides/fisiologia , Proteômica , Receptores de Interleucina-6 , Índice de Gravidade de Doença , Transcriptoma , Tuberculose/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA